The Trump administration opposed Louisiana’s push to restrict abortion pills by mail but refused to defend the Biden-era FDA safety analysis.

The 5th Circuit will hear Louisiana’s challenge to Biden-era abortion by mail rules as the FDA conducts a new mifepristone safety review.

The Trump administration opposed Louisiana’s push to restrict abortion pills by mail but refused to defend the Biden-era FDA safety analysis.